Home Global Resources State Regulations Privacy Policy Legal Notice Site Map Tell A Friend Change Text SizeSML Printer Friendly Pages
Ortho-McNeil Neurologics, Division of Ortho-McNeil-Janssen Pharmaceuticals, Inc. Ortho-McNeil Neurologics, Division of Ortho-McNeil-Janssen Pharmaceuticals, Inc.
Our Company Innovation & Research Our Products Therapeutic Areas Transparency Our Giving Medical Education News Center Contact Us
MEDIA RESOURCES

 
 
NEWS CENTER

 
Following are recent news releases issued by Ortho-McNeil Neurologics ® .

For additional media resources, click here

11/16/09   National Expressions of Courage Art Contest Unveils Stories of Inspiration.
Artwork by People with Epilepsy Showcases Talent and Depth of Neurological Condition.
08/21/09   The U.S. Food and Drug Administration (FDA) issued a complete response letter regarding the New Drug Application (NDA) for carisbamate, an anti-epileptic drug in development, announced Ortho-McNeil-Janssen Pharmaceuticals, Inc.
05/11/09   Every Picture Tells a Story, Particularly for Those with Epilepsy
Expressions of Courage ® Art Contest for People with Epilepsy Now Accepting Entries
04/30/09   Study Analyzing Dialogue Between Neurologists and Epilepsy Patients Identifies Significant Gaps
Physicians Unaware of Many Side Effects and Mood and Behavior-Related Problems
04/29/09   Studies Uncover High and Often Overlooked Costs Associated with Epilepsy Prevalence of Comorbidities Can Result in Significant Costs to Third-Party Payors
03/31/08   People with Epilepsy Encouraged to Submit Artwork as part of National Expressions of Courage® Art Contest
03/28/08   Leading Epilepsy Advocates Propose Strategies to Heighten Treatment Expectations and Close Patient and Physician Communication Gaps